Peptidomimetics bridge the gap between peptides and small-molecule drugs, combining the specificity of peptides with improved drug-like properties.
What Are Peptidomimetics?
The Goal
Retain peptide-like **specificity and potency** while gaining small molecule-like **pharmacokinetics**.
Design Strategies
Backbone Modifications
- Block hydrogen bond donors
- Reduce protease recognition
- Increase lipophilicity
- Example: Cyclosporin A (7 N-methyl residues)
- Mirror images of natural amino acids
- Invisible to most proteases
- Example: D-Ser in semaglutide
- Side chain on nitrogen, not α-carbon
- No chiral center, no hydrogen bond donors
- Resist proteases completely
- Extra methylene in backbone
- Altered hydrogen bonding pattern
- Form stable 14-helix structures
Side Chain Modifications
- Expand chemical space
- Optimize binding interactions
- Example: Aib (α-aminoisobutyric acid)
- Restrict φ/ψ angles
- Pre-organize structure
- Reduce entropic cost of binding
Amide Bond Isosteres
| Isostere | Properties |
| -CH₂-NH- (reduced) | Flexible, stable |
| -CO-N(CH₃)- | N-methylated |
| -CS-NH- (thioamide) | Protease resistant |
| Triazole | Click chemistry product |
| E-alkene | Rigid, non-polar |
Stapled Peptides
Advantages
1. **Structural stability** — Pre-organized for binding
2. **Protease resistance** — Backbone protected
3. **Cell permeability** — Can enter cells
4. **Intracellular targets** — Access PPIs
Clinical Development
**ALRN-6924:**
- Stapled p53 peptide
- Inhibits MDM2 and MDMX
- Reactivates p53 tumor suppressor
- Phase 1/2 clinical trials
Cyclic Peptides
Natural Examples
| Peptide | Size | Source | Use |
|---------|------|--------|-----|
| Cyclosporin A | 11 AA | Fungus | Immunosuppression |
| Vancomycin | 7 AA | Bacteria | Antibiotic |
| Daptomycin | 13 AA | Bacteria | Antibiotic |
Cyclization Strategies
- **Head-to-tail** — N to C connection
- **Disulfide** — Cysteine cross-link
- **Lactam** — Side chain to backbone
- **Thioether** — Cys to dehydroalanine
Macrocyclic Peptides
Natural Product-Inspired
- Combine peptide with non-peptide elements
- "Peptide-small molecule hybrids"
- Expand chemical space
Success Stories
| Drug | Type | Target | Indication |
| Cyclosporin A | Cyclic, N-methylated | Cyclophilin | Immunosuppression |
| Semaglutide | D-AA, Aib, lipidated | GLP-1R | Diabetes, obesity |
| Romidepsin | Cyclic depsipeptide | HDAC | Cancer |
| Pasireotide | Cyclized somatostatin | SSTR | Cushing's disease |